More News

17 Nov 2017 Evelo Biosciences and Mayo Clinic Collaborate to Advance Monoclonal Microbials for the Treatment of Inflammatory and Neuroinflammatory Diseases
17 Nov 2017 Oncolytics Biotech® Inc. and Adlai Nortye Enter into USD $86.6 Million Regional Licensing Agreement for REOLYSIN®
17 Nov 2017 Ionis Pharmaceuticals Licenses Second Orally Delivered Antisense Drug to Janssen
15 Nov 2017 Arvinas Expands Strategic License Agreement with Genentech
15 Nov 2017 ITUS Corporation Licenses CAR-T Technology from The Wistar Institute
15 Nov 2017 Torque, a Flagship Pioneering Company, Launches Platform to Develop a New Class of Deep-Primed™ Immune Cell Therapies, Financed with $25M Series A and Led by a Veteran Management Team
15 Nov 2017 Monopar Therapeutics, Inc. Announces Acquisition of GPX-150, a Broad Spectrum Phase II Cancer Drug Candidate, Closing on $9.7M in Financing, and Filing of Form 10 Registration Statement
15 Nov 2017 Seres Therapeutics, MD Anderson Cancer Center, and the Parker Institute for Cancer Immunotherapy Announce a Collaboration to Support the Investigation of Microbiome Therapeutics for Immuno-Oncology
15 Nov 2017 Locus Biosciences Closes $19 Million Series A Led by ARTIS Ventures for CRISPR-Cas3 Antimicrobials
15 Nov 2017 Loxo Oncology Announces Global Development and Commercialization Partnership with Bayer for Larotrectinib and LOXO-195
15 Nov 2017 Imcyse continues patient enrolment in its Phase 1b trial in type 1 diabetes
14 Nov 2017 Excision BioTherapeutics Exclusively Licenses New CRISPR-Cas Gene Editors from UC Berkeley, to be Used for Viral Infections
14 Nov 2017 Homology Medicines and Novartis Enter Collaboration to Develop New Treatments Using Homology's Proprietary Gene Editing Technology
13 Nov 2017 Zymeworks Announces License Agreement with Johnson & Johnson Innovation to Develop and Commercialize Next Generation Bispecific Antibody Therapeutics
13 Nov 2017 Arcus Biosciences Announces $107 Million Series C Financing Led by GV and Initiation of Two Clinical Trials
13 Nov 2017 CRISPR Therapeutics and Casebia Collaborate with CureVac on mRNA for Gene-Editing Programs
09 Nov 2017 Ionis Licenses Novel Antisense Drug for the Treatment of Centronuclear Myopathy to Dynacure
09 Nov 2017 Sanofi, Principia agree to develop multiple sclerosis drug candidate
09 Nov 2017 Neurimmune Announces Collaboration With Ono Pharmaceutical in Neurodegenerative Diseases Field
08 Nov 2017 Boehringer Ingelheim and MiNA Therapeutics to Develop Novel Treatment Approaches for Fibrotic Liver Diseases
08 Nov 2017 CERENIS Therapeutics Acquires LYPRO Biosciences Expanding Its HDL Strategy Into Immuno-Oncology and Chemotherapeutic Drug Delivery
07 Nov 2017 NousCom Raises €42 Million Series B Financing
06 Nov 2017 Collaboration project agreement between MAB Discovery GmbH and BioNTech AG
03 Nov 2017 iPharma Enters Into Licensing Agreement With Boehringer Ingelheim to Obtain Worldwide Rights to FAK Inhibitor Oncology Development Program
03 Nov 2017 Novartis and Amgen announce expanded collaboration with Banner Alzheimer's Institute in pioneering prevention program

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing